Since dysfunction in the BDNF/TrkB signaling and in the endosomal machinery has been involved in several neurodegenerative diseases (Zhang et al. 2021), an in‐depth understanding of their interaction underlying neuronal plasticity will pave the way for the identification of new pharmacological targets able to preserve brain plasticity. This evidence concerns the gene NTRK2 and neurodegenerative disease.